Notes
District Health Board
Reference
PHARMAC. Thousands of New Zealanders will benefit from advances in treatment. Internet Document : 10 May 2018. Available from: URL: https://www.pharmac.govt.nz/news/media-2018-05-10-advances-in-treatment/
Rights and permissions
About this article
Cite this article
Aflibercept and rivaroxaban to be funded in New Zealand. PharmacoEcon Outcomes News 803, 3 (2018). https://doi.org/10.1007/s40274-018-4930-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4930-2